ZonMw: The Netherlands Organisation for Health Research and Development
Phase 2
2011-09-01
The aim of the current project is to validate PDE4 inhibitors as a target for cognition
enhancers (proof-of-concept) using a translational behaviour-EEG approach. The project will
demonstrate whether memory, but also attention, information processing or executive function
improves with the PDE4 inhibitor roflumilast in healthy humans.
The aim of the current project is to validate PDE4 inhibitors as a target for cognition
enhancers (proof-of-concept) using a translational behaviour-EEG approach. The project will
demonstrate whether memory, but also attention, information processing or executive function
improves with the PDE4 inhibitor roflumilast in healthy humans.
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Completed
AstraZeneca
Phase 4
2011-09-30
To demonstrate the additional benefit of roflumilast when added on to fixed-dose combination
(FDC) LABA/ICS in the reduction of exacerbations in subjects with severe to very severe COPD.
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Completed
Forest Laboratories
Phase 4
2011-09-30
To demonstrate the additional benefit of roflumilast when added on to fixed-dose combination
(FDC) LABA/ICS in the reduction of exacerbations in subjects with severe to very severe COPD.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
